MX2009004682A - Uso de dmae para el tratamiento de deficit cognitivo ligero. - Google Patents

Uso de dmae para el tratamiento de deficit cognitivo ligero.

Info

Publication number
MX2009004682A
MX2009004682A MX2009004682A MX2009004682A MX2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A
Authority
MX
Mexico
Prior art keywords
dmae
treatment
cognitive impairment
mild cognitive
sole agent
Prior art date
Application number
MX2009004682A
Other languages
English (en)
Spanish (es)
Inventor
Pierre Fabre
Christophe Przybylski
Bruno Dubois
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MX2009004682A publication Critical patent/MX2009004682A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MX2009004682A 2006-10-31 2007-10-31 Uso de dmae para el tratamiento de deficit cognitivo ligero. MX2009004682A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0609548A FR2907679B1 (fr) 2006-10-31 2006-10-31 Utilisation de dmae pour le traitement de deficit cognitif leger
PCT/EP2007/061737 WO2008053011A1 (fr) 2006-10-31 2007-10-31 Le dmae en tant qu'agent unique pour le traitement de deficit cognitif leger

Publications (1)

Publication Number Publication Date
MX2009004682A true MX2009004682A (es) 2009-09-28

Family

ID=38050144

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004682A MX2009004682A (es) 2006-10-31 2007-10-31 Uso de dmae para el tratamiento de deficit cognitivo ligero.

Country Status (18)

Country Link
US (1) US8207218B2 (enExample)
EP (1) EP2083814B1 (enExample)
JP (1) JP2010508253A (enExample)
KR (1) KR20090082428A (enExample)
CN (1) CN101528220A (enExample)
AR (1) AR063764A1 (enExample)
AU (1) AU2007316137A1 (enExample)
BR (1) BRPI0718263A2 (enExample)
CA (1) CA2667983A1 (enExample)
FR (1) FR2907679B1 (enExample)
IL (1) IL198463A0 (enExample)
MA (1) MA30925B1 (enExample)
MX (1) MX2009004682A (enExample)
NO (1) NO20092099L (enExample)
RU (1) RU2009120137A (enExample)
TN (1) TN2009000159A1 (enExample)
WO (1) WO2008053011A1 (enExample)
ZA (1) ZA200903626B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150157046A1 (en) * 2013-12-10 2015-06-11 Lifewave, Inc. Nutritional product composition for the mind
EP4736750A3 (en) * 2022-05-02 2026-07-15 Emocog Co., Ltd. Test method and apparatus for evaluating cognitive function decline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003981A2 (en) * 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
US20060211721A1 (en) * 2005-03-21 2006-09-21 Roberts Alan R Nutraceutical formulation of a cognitive enhancement system

Also Published As

Publication number Publication date
TN2009000159A1 (fr) 2010-10-18
BRPI0718263A2 (pt) 2014-01-07
ZA200903626B (en) 2010-07-28
MA30925B1 (fr) 2009-11-02
FR2907679A1 (fr) 2008-05-02
US8207218B2 (en) 2012-06-26
WO2008053011A1 (fr) 2008-05-08
RU2009120137A (ru) 2010-12-10
AU2007316137A1 (en) 2008-05-08
US20090298908A1 (en) 2009-12-03
EP2083814A1 (fr) 2009-08-05
IL198463A0 (en) 2010-02-17
CA2667983A1 (fr) 2008-05-08
AR063764A1 (es) 2009-02-18
FR2907679B1 (fr) 2009-10-30
EP2083814B1 (fr) 2013-03-20
JP2010508253A (ja) 2010-03-18
NO20092099L (no) 2009-07-17
KR20090082428A (ko) 2009-07-30
CN101528220A (zh) 2009-09-09

Similar Documents

Publication Publication Date Title
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
UA95975C2 (ru) N-метиламинометилизоиндольные соединения, композиции, содержащие их, и способы их применения
TW200745078A (en) Isoindole-imide compounds and compositions comprising and methods of using the same
MX2011012122A (es) Derivados de tiofeno.
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
ZA200806778B (en) N-Hydroxyacrylamide compounds
MX2009013501A (es) Compuestos piperidinicos y sus usos.
WO2009032843A3 (en) Deuterated ethambutols and their use
WO2011153458A3 (en) Compositions and methods for inhibition of or treatment of dengue virus infection
TW200639156A (en) New compounds
GB2446341A (en) Method and system for transdermal drug delivery
WO2009078978A3 (en) Compositions containing polyglycidol-based polymers and uses thereof
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
WO2008004100A9 (en) Therapeutic compounds
WO2007121471A3 (en) Dialkyl ether delivery agents
UA94042C2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса
TW200719903A (en) Compositions for the treatment of neoplasms
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
MY160963A (en) Sustained-release therapeutic agent for hypertension and renal dysfunction
AU2016219606A1 (en) Pharmaceutical composition for treating or preventing burn injuries

Legal Events

Date Code Title Description
FA Abandonment or withdrawal